Barnes And Thornbug LLP
Website: https://btlaw.com/
Intellectual Property
Barnes & Thornburg’s Intellectual Property Department, with more than 130 attorneys and professionals, is one of the largest intellectual property practice groups found in a full-service law firm. Our practice covers a broad spectrum of services, including strategic IP portfolio services, prosecuting and litigating patents, trademarks and copyrights, enforcement of patents and trademarks, and defense of IP enforcement actions.
Our IP practice advises and helps a diverse and multinational roster of clients. From electrical and mechanical engineering, to chemistry and microbiology, to computer technology and business methods – our attorneys’ background and experience in several technical disciplines positions us to meet a variety of sophisticated business and inventorship needs.
Life Sciences
Barnes & Thornburg provides a wide range of interdisciplinary legal services to organizations engaged in biotechnology, pharmaceuticals, medical and laboratory devices, health services and bioinformatics. Most of the lawyers in our biotech practice have educational and practical research experience pertinent to the biotechnology industry and many hold advanced degrees in organic chemistry, pharmacology, molecular biology, genetics, immunology and microbiology. We understand chemistry, biotech, pharmaceutical, and medical device technologies. In addition, our intellectual property practice includes professionals with advanced degrees in molecular biology, chemistry, organic chemistry, biochemistry, genetics, biology, pharmacology, immunology, microbiology, biotechnology, bioengineering, physics, mechanical engineering, electrical engineering, industrial engineering, and civil engineering.
Our team represents a wide array of clients in this industry – from startups to Fortune 500 companies. Some of our representative clients include 3M Company, DePuy Orthopaedics, Inc., Eli Lilly and Company, Johnson & Johnson, H.D. Smith Wholesale Drug Co., Hillenbrand, \
Carpmaels & Ransford
Website: https://www.carpmaels.com/
Carpmaels & Ransford LLP is a leader in the European IP market, having driven innovation in the industry for over 200 years. The firm advises clients on all aspects of intellectual property, including drafting, filing and prosecuting patent and trademark applications; drafting and negotiating licence agreements and other commercial IP agreements; advising on the transfer of property rights; assisting clients with patent restoration matters; and conducting enforcement and revocation litigation.
The firm has one of Europe’s largest IP teams serving blue-chip clients across the globe, including Johnson & Johnson, Bristol Myers Squibb, Novartis, Ionis Pharmaceuticals, Mars, Gilead, Raytheon, Regeneron, Takeda, Allergan and Xeros. The firm’s attorneys have considerable technical knowledge, bringing together experience from industry-leading companies, academic research at leading universities and extensive patent expertise in the areas of pharmaceuticals, biotechnology, engineering, tech, chemistry, materials, supplementary protection certificates and information and communication technologies and standards.
Critical 13-Year-Old Mistake in Stormy’s
‘Trump Extortion’ Plot and Real Reason
for NDAAD&D - Volo's Guide to Cormyr (2e) - Flip eBook Pages 1-50
Through its fully integrated dispute resolution and transactions teams, the firm is able to provide a holistic service to clients which supports their IP needs from inception to commercialisation.Thedispute resolution team, made up of experienced solicitors, barristers and patent attorney litigators, represents clients at all levels of the European Patent Office. The team is also adept at conducting enforcement litigation and revocation actions before the UK Intellectual Property Office and patent, copyright, trademark and other IP litigation in the English courts and the Court of Justice of the European Union, often advising in cases where parallel or related litigation is ongoing in courts across Europe or in the United States.
As a European IP firm with litigators and patent attorneys under one roof, Carpmaels & Ransford is looking forward to offering clients the chance to both obtain UPs using the existing EPO procedure and enforce their patents across Europe in the UPC.
DERIS
Website: https://www.deris.com/
Deris is a one-stop shop for IP services with one of the largest and internationally regarded IP prosecution and advisory team.
We have been the pioneer in shaping the IP landscape by obtaining the precedent decisions &participating the preparation of the IP legislation upon the invitation of the legislative bodies. We provide a wide spectrum of high-quality services that are essential for securing, maintaining and enforcing IP rights.
Our services and counseling are supported by the trademark attorneys and technical experts, who are nationaland Europeanpatentattorneys, under a unique service approach combining longstanding enforcement experience with prosecution-technical expertise.Our goal is to secure enforceable IP rights in the market so that they can be transformed into sustainable commercial values.
EIP
Website: https://www.eip.com/uk/
EIP specialises in high-value and complex patent matters. Our multidisciplinary team combines patent attorneys, litigators and commercial IP lawyers, and we have specialists in three of the world’s main patent markets - Germany, UK and US, and now also in the Nordics through our recent expansion into Sweden.
The benefit of this combination is well illustrated by EIP’s successful representation of clients in high stakes patent litigation before the UK High Court, Court of Appeal and Supreme Court and before the German District and Federal Courts.
Our contentious expertise extends to conducting offensive and defensive oppositions before the European Patent Office, often involving multiple parties and relating to cutting edge platform technologies, to representing clients in national litigation proceedings in the UK and Germany, and since 1 June 2023, also the UPC.
Our litigation practice has built an enviable reputation for quality and success amongst its competitors and clients, with a strong track record including a landmark ruling on Standard Essential Patents (SEPs) from the UK Supreme Court. Our patent attorneys work hand-in-hand with the litigation team in the UK and Germany, to provide technical expertise and put forward the very best case on large scale international patent litigation matters.
In addition to our existing UK, German and Swedish capabilities, EIP Amar, an alliance between EIP and Amar Goussu Staub in Paris, is a dedicated, experienced and technically skilled team of patent litigation specialists created to support clients in any high-stakes litigation before the UPC.
EIP is increasingly involved in advisory and strategic project work in relation to the enforcement of patent rights, including portfolio analyses, infringement and validity analyses and claim charting, and strategic IP advice such as due diligence related to acquisitions and joint ventures.
EIP’s Life Sciences team offers multi-qualified and multi-disciplinary teams to suit the specific needs of each client. Innovations in this sector are increasingly intersectional and, by bringing together life sciences expertise with EIP’s long established strengths in areas such as artificial intelligence and machine learning, our team provides an inter-disciplinary life sciences offering that keeps pace with such innovations.
Gemini Law
Website: http://www.geminilaw.com/
Gemini attorneys are among the most experienced and successful at helping manufacturers of biopharma products navigate IP barriers to access the U.S. market. Gemini has particular expertise in patent strategy and litigation relating to biosimilar, biobetter, generic and 505(b)(2) products, as well as collateral issues concerning the Hatch Waxman and BPCIA regulatory schemes. Gemini is also very experienced in counseling early-stage biotech companies to optimize patent portfolios and mitigate the risk posed by competitors’ IP, as well as IP issues related to licensing and development transactions. Gemini offers “end to end” counseling on IP issues in support of biopharma product development and launch in the U.S., including:
- Litigation risk mitigation and avoidance
- Patent & trade secret design-around strategies
- Patent portfolio optimization
- Biosimilar (BPCIA) litigation & regulatory strategy
- Hatch Waxman litigation & regulatory strategy
- "Biobetter" & "fast follow-on" product litigation & regulatory strategy
- Pharmaceutical device-related litigation & regulatory strategy
- IP & regulatory issues concerning healthcare AI
- CREATES Act requests & litigation
- Section 1782 discovery requests for use in foreign litigation
- Global coordination of litigation strategy concerning biosimilar, generic and biobetter products
- Patent landscaping and freedom-to-operate opinions
- IP-related licensing, development & manufacturing transactions
- Lobbying and legislative initiatives relating to the BPCIA and Hatch Waxman laws
Marks & Clerk
Website: https://www.marks-clerk.com/
Marks & Clerk is an international law firm specialising in intellectual property (IP) law. With a vast network of over 650 professionals across the world, including a qualified team of experienced patent and trademark associates, the firm offers comprehensive technical expertise covering all aspects of intellectual property matters, such as patents, trademarks, designs and copyright. Its services encompass worldwide protection, portfolio management, strategic advice, commercial guidance, licensing, enforcement, clearance and searches, validity and infringement opinions, due diligence and litigation. Operating through a network of offices in Canada, Europe and Asia, Marks & Clerk consistently delivers high-quality, seamless and cost-effective services to clients both locally and globally.
Pearce IP
Website: https://www.pearceip.law/
Pearce IP is a boutique firm offering intellectual property specialist lawyers, patent attorneys and trade mark attorneys to the life sciences industries (in particular, pharmaceutical, biopharmaceutical, biotech, ag-tech and food tech). Pearce IP is recognised by MIP has the only leading regional IP firm with a female founder, and is certified by WEConnect International as women owned.Pearce IP is the 2021 ‘Intellectual Property Team of the Year’ (Lawyers Weekly Australian Law Awards) and was shortlisted for the same award in 2022. Pearce IP is ranked in IAM Patent 1000 and Managing IP (MIP) IP Stars, in Australasian Lawyer 5 Star Awards as a ‘5 Star’ firm, and the Legal 500 APAC Guide for Intellectual Property.
Our leaders have been recognised in virtually every notable IP listing for their legal, patent and trade mark excellence including: IAM Patent 1000, MIP IP Stars, Doyles Guide, WIPR Leaders, 5 Star IP Lawyers, Best Lawyers, and Australasian Lawyer 5 Star Awards, and have been honoured with many awards including Australian Law Awards – IP Partner of the Year, Women in Law Awards – Partner of the Year, Women in Business Law Awards - Patent Lawyer of the Year (Asia Pacific), Most Influential Lawyers (Changemaker), among other awards.
Potter Clarkson
Website: https://www.potterclarkson.com/
Leading European intellectual property law firm, Potter Clarkson helps companies, organisations, and individuals across all sectors of business to understand, create, protect, and defend the commercial value of their innovations anywhere in the world. Its 200-strong specialist team of patent attorneys, trade mark attorneys, litigators, and licensing specialists, operate from dedicated offices in the UK, Sweden, and Denmark.
Recognised as one of Europe’s leading intellectual property law firms, Potter Clarkson is particularly well-known for its deep expertise in resolving life science disputes, its contentious practice routinely conducting high-profile litigation in key jurisdictions around the world as well as before the EPO, and now the UPC, with multiple actions currently on foot before this important new court.
Reddie & Grose
Website: https://www.reddie.co.uk/
Reddie and Grose is a European IP firm with offices in London, Munich and Cambridge. Our life sciences team is made up of specialist hubs that allow us to offer tailored servicesacross the entire IP spectrum. This blend of specialism anddiversity is recognised as one of our key strengths.
Our biotech hub is based out of our Cambridge office and has decades of experience taking clients from university spin-off to IPOs, as well as being experts in obtaining plant variety protection. Our London team specialises in managing the global patent portfolios and supplementary protection certificate strategies of multi-national companies based in the UK and Europe. In Munich, the team focuses on contentious pharmaceutical cases, regularly representing clients in EP opposition proceedings and advising on European product launch and litigation strategies.
Combining all this knowledge ensures that are clients will always benefit from rounded, commercially aware, advice of the highest standard.
Simmons & Simmons
Website: https://www.simmons-simmons.com/en/expertise/service/intellectual-property/patents
Our international Patent team seamlessly integrates the specialized expertise of a boutique practice with the extensive service offerings of a major international firm. Recognized in the market for our high-calibre clients and active involvement in leading global patent cases, we stand as a trusted force in the European legal landscape; with offices and well established patent experts in London, Amsterdam, Paris, Munich and Milan and with Pharma & Biotech as one of our firm’s four core sectors.
Leveraging our extensive experience, we adeptly guide clients through specialised procedures, including infringement seizures, preliminary injunctions, patent infringement actions, patent nullification actions, and non-infringement declarations. With over 45 years at the forefront of IP law and practice, our international reputation is anchored in a pre-eminent track record in complex patent litigation (alongside a market-leading IP transactions and regulatory practices). Our comprehensive suite of services offers a "one-stop-shop" for pharma and biotech clients needing advice and strategic partnership on patents and other areas of IP.
Simmons and Simmons has played a pivotal role in the development of the Unified Patent Court (UPC) system. Our partner, Kevin Mooney, is acknowledged as one of the "fathers of the UPC", if not “Mr UPC”. Positioned at the forefront of every aspect of the new system, we don't just advise on the law – we actively shape it.
Trevisan & Cuonzo
Website: https://www.trevisancuonzo.com/en/index.html
Please visit our website for more information.
Tsai, Lee & Chen
Website: http://www.tsailee.com.tw/?lc=en&
Please visit our website for more information.
